@carmonasfj.bsky.social
Scientific Strategy at VHIO & CancerCoreEurope | Science Communication at UNAV & UAB | Former Nature Medicine editor & cancer researcher
New paper in @natcancer.nature.com by Noelia Tarazona & team at INCLIVA.
Study reports a tumor-agnostic assay for detecting minimal residual #cancer based on whole-exome sequencing of longitudinal ctDNA samples after surgery www.nature.com/articles/s43... #liquidbiopsy
Study reports a tumor-agnostic assay for detecting minimal residual #cancer based on whole-exome sequencing of longitudinal ctDNA samples after surgery www.nature.com/articles/s43... #liquidbiopsy
June 29, 2025 at 9:06 PM
New paper in @natcancer.nature.com by Noelia Tarazona & team at INCLIVA.
Study reports a tumor-agnostic assay for detecting minimal residual #cancer based on whole-exome sequencing of longitudinal ctDNA samples after surgery www.nature.com/articles/s43... #liquidbiopsy
Study reports a tumor-agnostic assay for detecting minimal residual #cancer based on whole-exome sequencing of longitudinal ctDNA samples after surgery www.nature.com/articles/s43... #liquidbiopsy
At #AACR25, @vhio.bsky.social clinician-scientist Irene Braña, global PI of the BoB platform study presented promising results of #immunotherapy in solid #cancer patients stratified by underlying molecular mechanisms leading to MSI.
Fantastic collaboration within @cancercoreeurope.bsky.social
Fantastic collaboration within @cancercoreeurope.bsky.social
May 29, 2025 at 8:30 AM
At #AACR25, @vhio.bsky.social clinician-scientist Irene Braña, global PI of the BoB platform study presented promising results of #immunotherapy in solid #cancer patients stratified by underlying molecular mechanisms leading to MSI.
Fantastic collaboration within @cancercoreeurope.bsky.social
Fantastic collaboration within @cancercoreeurope.bsky.social
Register to attend this talk by immunologist Gabriel Rabinovich, Group Leader at the #CaixaResearchInstitute.
He will walk us through his research journey—from the discovery of galectins to their clinical applications.
📅 March 12—18:30
📍 CosmoCaixa
🎟 Registration link: lnkd.in/epCGcc_3
He will walk us through his research journey—from the discovery of galectins to their clinical applications.
📅 March 12—18:30
📍 CosmoCaixa
🎟 Registration link: lnkd.in/epCGcc_3
February 22, 2025 at 10:30 AM
Register to attend this talk by immunologist Gabriel Rabinovich, Group Leader at the #CaixaResearchInstitute.
He will walk us through his research journey—from the discovery of galectins to their clinical applications.
📅 March 12—18:30
📍 CosmoCaixa
🎟 Registration link: lnkd.in/epCGcc_3
He will walk us through his research journey—from the discovery of galectins to their clinical applications.
📅 March 12—18:30
📍 CosmoCaixa
🎟 Registration link: lnkd.in/epCGcc_3
Last week we had a very productive visit to #GustaveRoussy and learned about our colleagues' work in clinical research, #cancer prevention, digital #medicine, survivorship and so much more.
Many opportunities for #collaboration within @cancercoreeurope.bsky.social!
Many opportunities for #collaboration within @cancercoreeurope.bsky.social!
December 2, 2024 at 6:46 PM
Last week we had a very productive visit to #GustaveRoussy and learned about our colleagues' work in clinical research, #cancer prevention, digital #medicine, survivorship and so much more.
Many opportunities for #collaboration within @cancercoreeurope.bsky.social!
Many opportunities for #collaboration within @cancercoreeurope.bsky.social!